baber/WOPTO huggingface dataset:
Patent PT-2433015-E (PT)
Title: Method for producing a cellular wheel
Inventor: MERZ KARL
IPC: B21D53/26
Filed: 2010-04-27
Abstract: The wheel has an outer sleeve (12) and an inner sleeve (14) defining a cellular structure (17) established from a network, where the network is formed in a cross-section of cellular wall components (19) and the cellular wheel is made of metal. Cell edges (20) are defined on two adjacent axial planes (21) of adjacent cylindrical surfaces (18a-18c). An annular space between the inner sleeve and the outer sleeve is divided by the cellular wall components in a set of rotationally symmetrical cells (22, 22', 22''). The cell edges are aligned parallel to an axis of rotation. An independent claim is also included for a method for producing a cellular wheel.
Patent PT-657440-E (PT)
Inventor: JAKOB-ROETNE ROLAND
IPC: C07D413/14
Filed: 1994-12-03
Abstract: The invention relates to oxazolidin-2-one derivatives of the formula   <IMAGE>  wherein     R is hydrogen or lower alkyl; X is cycloalkenyl; bicyclo[2.2.1]hept-2-yl, opt. substituted by phenyl-2-oxo-5-methoxymethyloxazolidinyl; bicyclo[2.2.1]hept-5-en-2-yl; adamantyl; or cycloalkyl or piperidine, optionally mono- or polysubstituted by halogen, amino, lower alkyl, nitrile, an oxo group, hydroxyimino, ethylenedioxy  or by -OR<1>, wherein R<1> is -CH(C6H5)2, -(CH2)nC6H5, lower alkyl, hydrogen, - (CH2)nNHCOCH3, -(CH2)nNH2, -(CH2)nSOCH3, -(CH2)nCN, -(CH2) nSCH3, -(CH2)nSO2CH3, -CO-lower alkyl, -COC6H5, opt. substituted by an oxazolidinyl group:  or by =CR<2>R<3>, wherein     R<2> is hydrogen or lower alkyl;   R<3> is hydrogen, nitrile, lower alkyl, phenyl or COO-lower alkyl;  or by -(CH2)nR<4>, wherein  R<4> is nitrile, amino, -NHCOCH3, -COC6H5Hal, phenyl or hydroxyl;  or by -COR<5>, wherein R<5> is lower alkyl, -CH=CH-C6H5, -C6H5CF3, -O-C(CH3)3 or -O-lower alkyl; or by -NR<6>R<7>, wherein     R<6> is hydrogen or -COCH3;   R<7> is -COCH3, benzyl or -(CH2)nNHCOC6H4Hal;     n is 1-3;   Y<1> is -CH= or -N=;   Y<2> is -CH=, -C(OH)=, -C(NO2)=, -C(NH2)=, -C(Hal)= or -N= and pharmaceutically acceptable salts of basic compounds of the formula I with acids. These novel compounds and their pharmaceutically acceptable salts can be used for the prevention or control of depressive states, panic and anxiety states, cognitive disorders and neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease.
Patent PT-826061-E (PT)
Title: Improvements in or relating to plant starch composition
Inventor: GIDLEY MICHAEL JOHN
IPC: C07H21/04
Filed: 1996-05-03
Abstract: Disclosed is a nucleotide sequence encoding an effective portion of a class A starch branching enzyme (SBE) obtainable from potato plants, or a functional equivalent thereof, together with, inter alia, a corresponding polypeptide, a method of altering the characteristics of a plant, a plant having altered characteristics; and starch, particularly starch obtained from a potato plant, having novel properties.
Patent PT-848720-E (PT)
Inventor: TOCQUE BRUNO
IPC: C07K16/00
Filed: 1996-09-02
Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
Patent PT-902783-E (PT)
Inventor: MAYHEW ERIC
IPC: C07D305/14
Filed: 1996-09-12
Abstract: Provided herein is a taxane having a hydrocarbon attached at the 2' and/or 7 positions, the hydrocarbon's alpha position being occupied by a "hydrolysis-promoting group" ("HPG"). Substitution of an HPG for the methylene unit ordinarily occupying the alpha position allows for enhanced in vivo hydrolysis of the hydrocarbon-taxane bond, and hence, for enhanced taxane therapeutic activity. Also provided herein are taxane-containing compositions, and methods of administering taxanes to animals, including those afflicted with cancers.
Patent PT-856208-E (PT)
Inventor: LAMB KARL J
IPC: H02K49/04
Filed: 1996-10-18
Abstract: An adjustable coupler has a rotary magnet rotor with magnet modules gaps from electroconductive elements on an electroconductive rotor. The magnet modules each have two side-by-side permanent magnets with their respective poles reversed and have a neutral plane between the magnets. The magnet modules can be turned for torque adjustment between a maximum torque position in which the neutral planes intersect at the rotary axis of the coupler, and a minimum torque position at which the magnet modules are turned 90 degrees from the maximum torque position.
Patent PT-850939-E (PT)
Inventor: PIERRE ALAIN
IPC: C07D471/04
Filed: 1997-12-22
Abstract: Ellipticine derivatives of formula (I) and their optical isomers, N-oxides and acid or base addition salts are new. R1 = 1-6C alkyl; R2, R4, R5 = H or 1-6C alkyl; R3 = H, 1-6C alkyl (optionally substituted by di-(1-6C alkyl)-amino on the C bonded to the ring) or 2-6C alkenyl; R6, R7 = H or 1-6C alkyl; or NR6R7 = heterocycle (optionally containing a second N, O or S heteroatom); or R5+R6 = (CH2)m; m = 2 or 3; and A = 1-10C alkylene; provided that A is not 1-6C linear alkylene if R3 = H.
Patent PT-892636-E (PT)
Inventor: BIANCHINI PIETRO
IPC: A61K47/36
Filed: 1997-02-04
Abstract: PCT No. PCT/IT97/00026 Sec. 371 Date Aug. 5, 1998 Sec. 102(e) Date Aug. 5, 1998 PCT Filed Feb. 4, 1997 PCT Pub. No. WO97/28787 PCT Pub. Date Aug. 14, 1997The polysaccharide fraction of tamarind gum, a product of natural origin obtained from the seeds of Tamarindus indica, is used for the production of a thickened ophthalmic solution having a pseudoplastic rheological behaviour and mucoadhesive properties. Said solution is useful as artificial tear and as vehicle for sustained release ophthalmic drugs. The concentrations of tamarind seed polysaccharide preferably employed in ophthalmic preparations for use as artificial tears, i.e. as products for replacing and stabilising the natural tear fluid, particularly indicated for the treatment of dry eye syndrome, are comprised between 0.7 and 1.5% by weight. The concentrations of tamarind seed polysaccharide preferably employed in the production of vehicles (i.e. delivery systems) for ophthalmic drugs, having the function of prolonging the permanence time of said medicaments at their site of action, are comprised between 1 and 4% by weight.
Patent PT-1011695-E (PT)
Inventor: SCHMIDT RICHARD A
IPC: A61P15/00
Filed: 1998-07-15
Abstract: The present application is directed to the use of a therapeutically effective amount botulinum toxin in the preparation of a pharmaceutical composition for treating a patient with a neurogenic bladder dysfunction, wherein the composition is to be administered by injection into a bladder wall of a patient with said neurogenic bladder dysfunction, thereby treating a symptom of said neurogenic bladder dysfunction.
Patent PT-1080192-E (PT)
Inventor: FLAD HANS-DIETER
IPC: A61K31/70
Filed: 1999-05-20
Abstract: The invention relates to oligoribo- and oligodesoxyribonucleotides which are suitable for treating pathological conditions that are accompanied by increased cell proliferation. Said oligoribo- and oligodesoxyribonucleotides are characterised in that they are able to hybridise with the mRNA which codes the protein Ki-67, this protein being associated with the cell cycle.
Patent SG-137194-G (SG)
Title: Pipe connection
Inventor: HOPPERDIETZEL SIEGFRIED DR
IPC: H02G9/06
Filed: 1994-09-26
Abstract: The invention relates to a pipe connection consisting of plastic, metal or suchlike materials. In this case, the insertion end of a pipe acting as a male die is reduced in its external diameter by forming a conical transition region to the unobstructed width of the subsequent pipe, which is used as the female. According to the invention, at least one impact zone is provided on the conical transition region from the pinched insertion end to the actual pipe diameter. This impact zone forms the impact surface for the end surface of the subsequent pipe.
Patent IE-820295-L (IE)
Title: Hinge assembly for use with agricultural implements
IPC: E05F15/04
Filed: 1982-02-10
Abstract: A first segment usually attached to a tractor is pivotally linked by a first bolt to a second pivotal segment. For example, which may be moved between an extended outward working position and a retracted, non-working inward position. A hydraulic cylinder and piston are mounted on the fixed segment and the free end of the piston is pivotally linked to the base of a substantially U-shaped member. One arm of the U-shaped member is pivotally linked to the fixed segment, and the other arm of the U-shaped member is pivotally linked to one end of a coupling member. The other end of the coupling member is pivotally linked to the pivotal segment. In the extended position, the arms of the U-shaped member pivot down wardly, and the end of the coupling member connected to the pivotal segment comes to rest between the arms of the U-shaped member in horizontal alignment with the links connecting the U-shaped member to the fixed segment and pivotal segment. Arms of the U-shaped member come to rest in a position substantially surrounding the bolt connecting the fixed segment to the pivotal segment, and the two segments are thereby locked in the extended position.
[US4400994A]
Patent IE-810316-L (IE)
Title: Rosmarinic acid.
IPC: C07C69/732
Filed: 1981-02-17
Abstract: The present invention is related to a new process for producing rosmarinic acid by extraction of certain plants, and in particular of plants of balmmint (Melissa officinalis).
Patent IE-39183-L (IE)
Title: Friction false-twisting of yarns
IPC: D02G1/08
Filed: 1974-03-19
Abstract: The invention is related to a false twister for the production of synthetic textured or stretch-type yarns or filaments, consisting of two or more successive internal friction twisters, wherein the inlet-end friction surfaces of the internal friction twister mouthpieces have a high coefficient of friction whilst the friction surfaces of the outlet mouthpieces have a low coefficient of friction in relation to the friction surfaces at the inlet end.
[US3879927A]
Patent IE-36348-L (IE)
Title: Device for germinating and drying malt
IPC: C12C1/00
Filed: 1972-05-02
Abstract: A device for effecting the germination and the drying of malt comprising vertical stack surrounded by several superimposed horizontal circular working chambers, each containing a horizontal rotatable rack upon which the malt to be treated is deposited. The circumferential wall of the stack is provided with adjustable ducts for the passage of drying air coming from a blower arranged in the stack and is conducted into the working chambers. Side stacks are arranged side by side and on the outside of the vertical stack and some have ducts which connect some of the adjacent side stacks with each other and with the working chambers for effecting a desired guide of the drying air into the working chambers, while one of said side stacks contains a blower for the germination of air and the other side stacks contain the drive devices for the malt turning-over mechanism for the vertical adjustment of the malt feeding mechanism and for the rotation of the racks.
[US3849255A]
Patent IE-840613-L (IE)
Title: Trim rewinder
IPC: B41L1/14
Filed: 1984-03-12
Abstract: A trim rewinder eliminates manual removal of trim, and increases rewinder capacity several-fold. A stripper portion of a bin of the rewinder strips wound trim from elongated members of the rewinder into the bin as the bin is removed.A pressure member wipingly presses trim tightly about the elongated members to compact the trim.
Patent IE-840652-L (IE)
Title: Triazoles
IPC: C07D521/00
Filed: 1984-03-15
Abstract: Triazole antifungal agents of the formula: <CHEM> where R is phenyl optionally substituted by 1 to 3 substituents each independently selected from F, Cl, Br, I, CF3, C1-C4 alkyl and C1-C4 alkoxy, or R is 5-chloropyrid-2-yl; and R<1> is H or CH3; and their O-esters, O-ethers and pharmaceutically and agriculturally acceptable salts. The compounds are useful as human and agricultural antifugal agents.
[EP0122056A1]
Patent IE-790674-L (IE)
Title: Erecting an offshore structure
IPC: E02B17/02
Filed: 1979-08-08
Abstract: Methods and apparatus for offshore operations including individually significant aspects comprising: 1. Methods and apparatus for providing lateral force transmitting arch means extending across a vessel passageway which is laterally bounded by upwardly projecting portions of a substructure and bounded on the top by an integrated deck: 2. Methods and apparatus for assemblying an integrated deck with a substructure wherein there are effected horizontal and vertical shock absorbing action, motion dampening, and desired alignment; and 3. Methods and apparatus for assemblying an integrated deck with a substructure wherein, at a relatively slower rate, an integrated deck is lowered into engagement with a substructure and, at a subsequent more rapid rate, a vessel initially supporting the integrated deck is vertically separated therefrom.
[US4242011A]
Patent IE-35203-L (IE)
Title: Anaesthetic compounds
IPC: A61K31/57
Filed: 1970-06-19
Abstract: 1317184 Injectable anaesthetics GLAXO LABORATORIES Ltd 11 June 1970 [20 June 1969] 31371/69 Heading A5B [Also in Division C2] Anaesthetic compositions suitable for use by parenteral administration comprise an aqueous solution containing at least 1mg/ml of 3α- hydroxy-5α-pregnane-11, 20-dione and a non- ionic surface-active agent serving to solubilize the steroid. Preferably they contain at least 1% by weight of the agent and this has an HLB value of 9-18. Suitable agents include polyoxyethylated derivatives of fatty glyceride oils, polyoxyethylene ethers of long-chain alcohols, polyoxyethylene - polyoxypropylene ethers, polyoxyethylene ethers of alkyl phenols, polyoxyethylated fatty acid esters of sugar alcohol anhydrides, long-chain alkanoyl mono- and di-alkanolamides and polyethylene glycol esters of long-chain fatty acids. The solubility of the anaesthetic steroid may be further increased by addition of a steroid of the formula: wherein R is an optionally substituted alkanoyl, aroyl or aralkanoyl group. These steroids are described and claimed in Specification 1317185. They also possess some anaesthetic activity.
[GB1317184A]
Patent FI-813951-L (FI)
Inventor: KLOSA JOSEF
IPC: C07D473/12
Filed: 1981-12-09
Abstract: New [8-(dialkylamino alkoxy)-caffeine]-platinum complex compounds of the general formula   <IMAGE>   are prepared from 8-(dialkylamino alkoxy)-caffeine and hexachloro platinic acid. The complex compounds are nonpoisonous, stable and infinitely durable. In pharmacological test series distinct cytostatic activity of the complex compounds is observed and they are suitable for use as active components in pharmaceutical products.
Patent FI-850248-L (FI)
Inventor: SCHENK HEINRICH
IPC: H04L27/08
Filed: 1985-01-18
Abstract: 1. Circuit arrangement for a digital level control having a control amplifier (RV), of adjustable amplification, which is actuating signals at predetermined intervals from a controller (ADD, T, SS, TV) in order to vary its output level in steps, and having a level discriminator (SUB), which, when the level transmitted as controlled variable by the control amplifier deviates from a set level, transmits to the controller as manipulated variable a signal indicating the direction of the control deviation, characterized in that the level discriminator (SUB) additionally determines the amount of the control deviation, and in that the controller (ADD, T, SS, TV) specifies, as a function of this amount of the control deviation, the intervals at which actuating signals are to be transmitted to the control amplifier.
Patent IE-861233-L (IE)
Title: 17-alpha-ethynyl steroid
IPC: C07J1/00
Filed: 1986-05-09
Abstract: Novel intermediates useful in the preparation of fluorophenoxyphenoxypropionates and derivatives thereof which possess herbicidal activity selectively in the presence of broadleaf crops.
Patent IE-891416-L (IE)
Title: Uncrosslinked hydrogel, process for its preparation and its¹uses as an article for medical and/or surgical purposes such¹as tubes, filaments, films, joints, implants and the like,¹particularly in ophthalmology
IPC: A61F2/14
Filed: 1989-05-01
Abstract: Non-cross-linked hydrogel, method for making it, and its uses in medicine and/or surgery, such as tubes, filaments, films, rings, implants and the like, especially in ophthalmolgy. The non-cross-linked hydrogel having a relatively high water content is made from a starting liquid composition (D) which comprises from 2 to 50 % of an acrylonitrile copolymer and of an olefinically unsaturated comonomer carrying anionic groups, optionally in salt form, the molar ratio of acrylonitrile to comonomer being between 90:10 and 100:0, a suitable solvent and a suitable non-solvent of the said copolymer, the solvent/non-solvent ratio being between 500:1 and 0.5:1 by weight, the said hydrogel having a microporous structure, an ionic capacity of between 0 and 500 mEq/kg of gel, a water content of between 50 and 98 %, and having a capacity for permanent deformation under stress, even at a temperature below 40 DEG C.
[EP0347267A1]
Patent IE-891542-L (IE)
Title: Peptides having t cell helper activity
IPC: A61K38/00
Filed: 1989-05-11
Abstract: Tetrapeptides and pentapeptides are disclosed and which have the biological activity of the molecule human thysplenin. Their respectives general formulas are: R-Arg-X-Y-Z-R<1> R<2>-Arg-X'-Ala-Y'-Z'-R<3> Also provided are pharmaceutical compositions containing the peptides and methods of use thereof.
[EP0342962A2]
Patent IE-842415-L (IE)
Title: Insulin derivatives
IPC: A61K38/00
Filed: 1984-09-21
Abstract: 1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE A medicament having a delayed action for the treatment of diabetes mellitus, comprising at least one insulin derivative of the formula I see diagramm : EP0137361,P16,F1  in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH2 and des-B30 human insulin Phe**B30 -NH2 and a pharmaceutically acceptable carrier. 1. Claims for the Contracting State : AT A process for the preparation of a medicament having a delayed action for the treatment of diabetes mellitus, which comprises bringing into a suitable dosage form at least one insulin derivative of the formula I  see diagramm : EP0137361,P17,F1  in which R**1 denotes H or H-Phe R**30 represents the radical of a neutral, genetically codable L-aminoacid whose OH group, where present, can be free or protected by a physiologically acceptable group, and R**31 denotes a physiologically acceptable neutral group blocking the carboxyl group, with the exception of des-B30 human insulin Leu**B30 -NH2 and des-B30 human insulin Gly**B30 -NH, and des-B30 human insulin Phe**B30 -NH2 Phe**B30 -NH2 and a pharmaceutically acceptable carrier.
Patent IE-862445-L (IE)
Title: Dentifrice composition
IPC: A61K8/81
Filed: 1986-09-12
Abstract: An oral dentifrice composition such as a toothpaste, dental gel, toothpowder, dental tablet or lozenge containing as anticalculus agent about 4.3% to about 7% of alkali metal pyrophosphates comprising at least 4.3% of tetrapotassium pyrophosphate alone or admixed with up to 2.7% of tetrasodium pyrophosphate, and as inhibitors against enzymatic hydrolysis of such agent in saliva, a fluoride and preferably up to about 3% of a synthetic anionic polymeric polycarboxylate, and use of such composition in a program of oral hygiene and/or for inhibiting dental calculus.
[US4806340A]
Patent IE-842952-L (IE)
Title: IMIDAZO £4,5-c| QUINOLINES AND QUINOLINES
IPC: C07D215/18
Filed: 1984-11-16
Abstract: Compounds of the types (I) and (II) are disclosed, <CHEM> wherein each R5 is independently selected from the group consisting of alkyl of one to about four carbon atoms, alkoxy of one to about four carbon atoms and halogen, and n is an integer from 0 to 2, with the proviso that if n is 2, then said R5 substituents together contain no more than 6 carbon atoms; R6 is selected from the group consisting of hydroxyalkyl of one to about six carbon atoms and cyclohexylmethyl; and R7 is selected from the group consisting of alkyl of one to about four carbon atoms and hydrogen. These compounds may be used as intermediates for the synthesis of 1H-imidazo[4,5-c]quinoline derivatives.
Patent IE-893183-L (IE)
Title: Metal matrix composite
IPC: C04B41/88
Filed: 1989-10-04
Abstract: The present invention relates to the formation of a metal matrix composite body by a spontaneous infiltration technique and thereafter thermo-forming the produced metal matrix composite body. Particularly, an infiltration enhancer and/or an infiltration enhancer precursor and/or an infiltrating atmosphere are in communication with a filler material (2) or a preform, at least at some point during the process, which permits molten matrix metal to spontaneously infiltrate the filler material (2) or preform. After formation of the metal matrix composite body, the body is subjected to a thermo-forming technique such as rolling, extruding, die casting, pressing, etc.
Patent NO-792401-L (NO)
Title: Digitalt kommunikasjonssystem.
Inventor: LONBERGER JOHN WILLIAM
IPC: H04L/
Filed: 1979-07-19
Abstract: Digitalt kommunikasjonssystem.
Patent NO-830453-L (NO)
Inventor: KASHIWA NORIO
IPC: C08F4/00
Filed: 1983-02-10
Abstract: A process for producing an olefin polymer or copolymer which comprises polymerizing or copolymerizing olefins or copolymerizing an olefin with up to 5 mole% of a diolefin in the presence of a catalyst comprising a titanium catalyst component containing magnesium, titanium, halogen and an electron donor, an organoaluminum catalyst component and a third catalyst component, characterized in that said catalyst is composed of (A) a titanium catalyst component containing magnesium, titanium, halogen and an electron donor essential ingredients, said electron donor being elected from the group consisting of (a) esters of polyfunctional compounds selected from polycarboxylic acids having 5 to 36 carbon atoms, polyhydroxy compounds having 6 to 28 carbon atoms and hydroxy-substituted carboxylic acids having 10 to 28 carbon atoms, (b) monocarboxylic acid esters of the formula RCOOR min  in which each of R and R min  represents a hydrocarbyl group having 1 to 20 carbon atoms at least one of them represents a branched-chain group, an alicyclic group, or an aryl ring-containing linear group and  (c) carbonic acid esters having 3 to 18 carbon atoms,  (B) an organoaluminium compound, and (C) an ester of phosphorous acid with an alcohol having 2 to 4 carbon atoms; and a catalyst composition used therefor. f
Patent NO-830727-L (NO)
Inventor: TSAU JOSEF HENGKO
IPC: C07K5/075
Filed: 1983-03-03
Abstract: The invention relates to metal complexes of dipeptide sweeteners, such as L-aspartyl-L-phenylalanine methyl ester, with improved dissolution rate, solubility and stability.
Patent NO-850043-L (NO)
Inventor: RADVAN BRONISLAW
IPC: B29C67/20
Filed: 1985-01-04
Abstract: A process for moulding articles of fibre reinforced plastics material which includes heating and moulding a sheet of consolidated thermoplastics material which has dispersed therein from 20 to 70% by weight of reinforcing fibres which have a high modulus of elasticity (as herein defined) and between about 7 and about 50 millimetres long so that the stresses embodied in the glass fibres cause the matrix to expand into the configuration of the mould and become porous.